TCTR20141002001已完成未知
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational study
Health Intervention and Technology Assessment Program (HITAP)0 个研究点目标入组 6,399 人开始时间: 2014年10月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6,399
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •ï¿½ Sign informed consent which was approved by the institutional review board (IRB)/ independent ethics committees (IECs) of each hospital.
- •ï¿½ age ≥ 18 years of either gender.
- •ï¿½ be patients with retinal diseases who are treated or will be treated (previously untreated) with IVB or IVR before participating in this study.
- •ï¿½ no contraindication to IVB or IVR such as allergy to the active ingredient or their excipients.
- •ï¿½ no condition of infection around or at the eyes before receiving IVR.
- •ï¿½ can participate in the study for at least 6 months after the enrollment.
排除标准
- •ï¿½ have contraindication of bevacizumab or ranibizumab and their excipients
- •ï¿½ switch between the investigational drugs within 6 months before the enrolment and during the 6-month of the study period
- •Data collection of any subjects will be terminated when
- •ï¿½ switch between the investigational drugs during the follow up period
- •ï¿½ subjects want to withdraw from the study
研究者
相似试验
已完成
2 期
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.Macular edemaEye - Diseases / disorders of the eyeCentral retinal vein occlusionACTRN12622000267752Salahuddin34
已完成
不适用
The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases.choroidal neovascularization, retinal vein occlusion, diabetic retinopathy, diabetic maculopathy, neovascular glaucomaJPRN-UMIN000013974Department of Ophthalmology, Matsumoto Dental University3
已完成
不适用
Evaluation of Intravitreal injection of Bevacizumab for treatment of Chronic Central Serous Chorioretinopathychronic central serous chorioretinopathy.Disease of the eye and adnexaIRCT201202198983N1Guilan Universoty of Medical Sciences, Pro-vice-chancellor for resea15
未知
1 期
To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalizatioARMD,BRVO,CRVO,DR,CNVJPRN-UMIN000000647Department of Ophtalmology of Keio University Hospital10
已完成
不适用
Evaluate the effect of intravitreal Bevacizumab injection for ocular proliferative diseaseschoroidal neovascularization,proliferative diabetic retinopathy, central retinal vein occlusion neovascular glaucomaJPRN-UMIN000020467agasaki University Hospital90